Shenzhen New Industries Biomedical Engineering Co., Ltd.

SZSE:300832.SZ

60.24 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q1
Revenue 1,124.7621,121.1291,203.3391,184.5741,017.2551,017.5361,042.92989.325875.859750.279879.766674.076742.835651.534668.175693.335532.371624.591600.274681.349288.753494.598446.791425.068315.13264.301264.301196.951196.951208.378208.378157.463157.463153.99153.99118.648118.648114.982114.98274.07974.079
Cost of Revenue 359.76322.258338.743367.163267.255289.822267.358261274.308207.316260.079231.641207.167170.984203.489205.388154.442156.402143.884115.27285.31199.68384.54490.24962.52657.53557.53540.23740.23750.8850.8838.16438.16438.9638.9626.41826.41833.28633.28619.1719.17
Gross Profit 765.002798.871864.596817.411750727.714775.562728.325601.551542.963619.687442.435535.668480.549464.686487.947377.929468.189456.39566.077203.441394.915362.247334.819252.604206.767206.767156.715156.715157.498157.498119.299119.299115.03115.0392.2392.2381.69681.69654.90954.909
Gross Profit Ratio 0.680.7130.7180.690.7370.7150.7440.7360.6870.7240.7040.6560.7210.7380.6950.7040.710.750.760.8310.7050.7980.8110.7880.8020.7820.7820.7960.7960.7560.7560.7580.7580.7470.7470.7770.7770.7110.7110.7410.741
Reseach & Development Expenses 101.897126.19123.04692.685101.45686.00599.26688.81283.18794.25991.04373.90858.50172.11757.97344.70140.25436.82833.57252.58727.59633.57929.80529.94126.26523.58623.5860014.02514.0250011.00711.007000000
General & Administrative Expenses 28.297-32.07564.758-5.55329.28-38.77766.1111.73220.86197.97183.814-13.56832.612-194.172209.877-73.27787.41-97.58489.6710.34914.133-7.26911.8179.1229.36222.16222.16216.13916.13968.24368.24313.14713.14711118.8448.8448.7598.7598.0148.014
Selling & Marketing Expenses 159.883-269.137408.173174.609159.401146.477157.567200.977125.289125.803123.681109.299100.003112.907103.71675.09278.24168.54173.45794.10661.011100.22385.17583.45959.38145.3345.3334.59734.59732.81832.81828.03928.03922.30122.30123.6223.6221.46221.46215.5215.52
SG&A 188.18-301.212472.932190.585196.882143.781223.678202.709146.15124.683207.49695.731132.614-81.265313.5931.815165.651-29.044163.12894.45575.14592.95496.99292.58268.74371.03571.03551.96251.962101.227101.22744.55544.55535.22235.22233.68833.68831.46331.46323.53523.535
Other Expenses -21.757464.484-274.765-17.783-0.306-0.777-0.091-1.036-16.94-18.639-46.26748.767-10.222-0.146-0.029-1.705-0.018-1.38-0.358-0.062-0.001-0.199-0.12-0.097-0.0420000000000000000
Operating Expenses 268.321289.462321.213283.27298.337229.786292.212322.39212.398100.302252.272218.405180.893120.591208.825196.879197.641180.455193.603150.08595.429146.672124.748115.85689.95957.50257.50246.52346.52391.77991.77942.58742.58731.27531.27528.67928.67931.25731.25723.5423.54
Operating Income 496.681509.409543.383534.141451.663497.928501.425459.816405.717442.66407.296294.951358.712366.127275.8292.266203.235286.466258.747426.299127.051247.881257.87232.594160.58134.406134.406103.83103.8354.10454.10473.98373.98378.94378.94357.6357.6349.29949.29930.80230.802
Operating Income Ratio 0.4420.4540.4520.4510.4440.4890.4810.4650.4630.590.4630.4380.4830.5620.4130.4220.3820.4590.4310.6260.440.5010.5770.5470.510.5090.5090.5270.5270.260.260.470.470.5130.5130.4860.4860.4290.4290.4160.416
Total Other Income Expenses Net -0.831-0.190.29419.6834.818-1.008-0.091-1.036-0.218-1.326-0.334-0.181-0.576-0.146-0.029-1.705-0.018-1.38-0.358-0.062-0.001-0.199-0.12-0.097-0.04217.5317.533.6533.6537.4097.4093.2633.2635.7775.7776.046.041.2331.2331.0411.041
Income Before Tax 495.85509.219543.677553.82486.48527.452501.334458.78405.499441.334406.962294.769358.137365.981275.771290.561203.217285.086258.389426.237127.05247.682257.75232.497160.538151.936151.936112.282112.28267.44667.44678.14478.14484.7284.7263.6763.6750.53250.53231.84331.843
Income Before Tax Ratio 0.4410.4540.4520.4680.4780.5180.4810.4640.4630.5880.4630.4370.4820.5620.4130.4190.3820.4560.430.6260.440.5010.5770.5470.5090.5750.5750.570.570.3240.3240.4960.4960.550.550.5370.5370.4390.4390.430.43
Income Tax Expense 58.33864.35463.23576.89260.25960.50264.62963.84950.43137.98751.96833.67149.65858.00238.66530.09435.07344.30435.75461.25716.335.42135.83832.09822.522.08622.08616.28516.2859.7119.71111.31911.31911.82311.82310.13110.1316.916.914.8314.831
Net Income 437.512444.865480.442476.928426.221466.949436.705394.931355.068403.347354.994261.099308.478307.979237.106260.467168.145240.782222.636364.98110.75212.261221.912200.399138.038129.85129.8595.99895.99857.73457.73466.82566.82572.89772.89753.5453.5443.62243.62227.01127.011
Net Income Ratio 0.3890.3970.3990.4030.4190.4590.4190.3990.4050.5380.4040.3870.4150.4730.3550.3760.3160.3860.3710.5360.3840.4290.4970.4710.4380.4910.4910.4870.4870.2770.2770.4240.4240.4730.4730.4510.4510.3790.3790.3650.365
EPS 0.560.5660.610.610.540.590.560.50.450.510.450.330.390.390.30.330.410.310.280.460.160.30.320.280.20.180.180.140.140.0820.0820.0980.0980.110.110.0780.0780.0640.0640.0390.04
EPS Diluted 0.560.5660.610.610.540.590.560.50.450.510.450.330.390.390.30.330.410.310.280.460.160.30.320.280.20.180.180.140.140.0820.0820.0980.0980.110.110.0780.0780.0640.0640.0390.04
EBITDA 495.943509.331543.793606.704539.326577.18551.145498.821445.553431.774441.268326.078390.045395.6305.412313.537226.495306.542262.786419.505108.013248.243242.303227.459170.513142.158142.158111.187111.18760.18860.18879.41879.41880.35480.35459.04559.04550.46850.46831.82831.828
EBITDA Ratio 0.4410.4540.4520.5120.530.5670.5280.5040.5090.5750.5020.4840.5250.6070.4570.4520.4250.4910.4380.6160.3740.5020.5420.5350.5410.5380.5380.5650.5650.2890.2890.5040.5040.5220.5220.4980.4980.4390.4390.430.43